This one day course has been designed to provide manufacturers with the knowledge and skills to interpret the requirements of the drug consultation process for devices containing ancillary medicinal substances.

This in-house course focuses on determination of the applicable European legislation for borderline products, and provides insight into further information and guidance related to the distinction between medical devices and medicinal products. This course also examines devices incorporating derivatives of human blood or plasma.

How will I benefit?

  • Attendance on this course will provide guidance on how to reduce risks and uncertainty in the EU regulatory process
  • Participants will gain an appreciation of the realistic timescales involved for the consultation process and an awareness of common mistakes to avoid, ensuring delays are minimized
“The tutor undertook the course with enthusiasm, and allowed each group member to provide input into the day.”